Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis

Oncotarget

Volumn 6, Issue 40, 2015, Pages 42557-42568

  Wang, Wenhong ^a,b   Zhang, Yingying ^a   Zhu, Bo ^a   Duan, Tanghai ^a   Xu, Qiugui ^a   Wang, Rui ^a   Lu, Liwei ^c   Jiao, Zhijun ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Array; Chemokine; Cytokine; Immune response; Immunity; Immunology and Microbiology Section; MicroRNA; Rheumatoid arthritis

Indexed keywords

CHEMOKINE; CYTOKINE; MICRORNA; MICRORNA 122-3P; MICRORNA 181D; MICRORNA 219-2-3P; MICRORNA 342-3P; MICRORNA 3925-3P; MICRORNA 3926; MICRORNA 4634; MICRORNA 4764-5P; MICRORNA 9-5P; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DAS28; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; GENE EXPRESSION PROFILING; GENETICS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ADULT; AREA UNDER CURVE; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMERASE CHAIN REACTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; TRANSCRIPTOME;

EID: 84952361957     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6449     Document Type: Article

References (37)

1. Ceribelli A, Satoh, M, Chan, EK. MicroRNAs and autoimmunity. Curr Opin Immunol. 2012; 24: 686-691.
2. Chhabra R, Saini, N. microRNAs in cancer stem cells: current status and future directions. Tumour Biol. 2014; 35: 8395-8405.
3. De-Guire, V, Robitaille R, Tetreault N, Guerin R, Menard C, Bambace N, Sapieha P. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clin Biochem. 2013; 46:846-860.
4. Zeng L, Cui, J, Wu, H, Lu, Q. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases. Autoimmunity. 2014; 47: 419-429.
5. Lin HM, Castillo L, Mahon KL, Chiam K, Lee BY, Nguyen Q, Boyer MJ, Stockler MR, Pavlakis N, Marx G, Mallesara G, Gurney H, Clark SJ, et al. Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer. Br J Cancer 2014;110:2462-2471.
6. Lindner K, Haier, J, Wang, Z, Watson, DI, Hussey, DJ, Hummel, R. Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers. Clin Sci (Lond). 2015; 128: 1-15.
7. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D, Chen X, Zhang H, Zhuang R, Deng T, Liu H, Yin J, et al. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 2011; 47: 784-791.
8. Medina-Villaamil V, Martinez-Breijo S, Portela-Pereira P, Quindos-Varela M, Santamarina-Cainzos I, nton-Aparicio LM, Gomez-Veiga F. Circulating MicroRNAs in Blood of Patients With Prostate Cancer. Actas Urol Esp. 2014; 38: 633-639.
9. Yamada H, Itoh, M, Hiratsuka, I, Hashimoto, S. Circulating microRNAs in autoimmune thyroid diseases. Clin Endocrinol (Oxf). 2014; 81: 276-281.
10. Wang H, Peng, W, Ouyang, X, Li, W, Dai, Y. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res. 2012; 160: 198-206.
11. Carlsen AL, Schetter AJ, Nielsen CT, Lood C, Knudsen S, Voss A, Harris CC, Hellmark T, Segelmark M, Jacobsen S, Bengtsson AA, Heegaard NH. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 2013; 65: 1324-1334.
12. Hachisuka S, Kamei, N, Ujigo, S, Miyaki, S, Yasunaga, Y, Ochi, M. Circulating microRNAs as biomarkers for evaluating the severity of acute spinal cord injury. Spinal Cord. 2014; 52: 596-600.
13. Holmdahl R, Malmstrom, V, Burkhardt, H. Autoimmune priming, tissue attack and chronic inflammation-the three stages of rheumatoid arthritis. Eur J Immunol. 2014; 44: 1593-159.
14. Solomon DH, Bitton, A, Katz, JN, Radner, H, Brown, EM, Fraenkel, L. Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis? Arthritis Rheumatol. 2014; 66: 775-782.
15. Miao CG, Yang YY, He X, Xu T, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J. New advances of microRNAs in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery. Cell Signal. 2013; 25: 1118-1125.
16. Dong L, Wang X, Tan J, Li H, Qian W, Chen J, Chen Q, Wang J, Xu W, Tao C, Wang S. Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis. J Cell Mol Med. 2014; 18: 2213-2224.
17. Lin J, Huo R, Xiao L, Zhu X, Xie J, Sun S, He Y, Zhang J, Sun Y, Zhou Z, Wu P, Shen B, Li D, Li N. A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2014; 66: 49-59.
18. Xu T, Huang, C, Chen, Z, Li, J. MicroRNA-323-3p: a new biomarker and potential therapeutic target for rheumatoid arthritis. Rheumatol Int.2014; 34: 721-722.
19. Chen SY. MicroRNA-223: a double-edged sword in rheumatoid arthritis. Rheumatol Int. 2014; 34: 285-286.
20. Murata K, Yoshitomi H, Tanida S, Ishikawa M, Nishitani K, Ito H, Nakamura T. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2010; 12: R86.
21. Murata K, Furu M, Yoshitomi H, Ishikawa M, Shibuya H, Hashimoto M, Imura Y, Fujii T, Ito H, Mimori T, Matsuda S. Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis. PLoS One. 2013; 8: e69118.
22. Qu X, Zhao M, Wu S, Yu W, Xu J, Xu J, Li J, Chen L. Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma. Med Oncol. 2014; 31: 219.
23. Ward J, Kanchagar C, Veksler-Lublinsky I, Lee RC, McGill MR, Jaeschke H, Curry SC, Ambros VR. Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis. Proc Natl Acad Sci U S A. 2014;111:12169-12174.
24. Pirola CJ, Fernandez GT, Castano GO, Mallardi P, San MJ, Mora Gonzalez Lopez LM, Flichman D, Mirshahi F, Sanyal AJ, Sookoian S. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis. Gut. 2015;64:800-812.
25. Liu Y, Gao G, Yang C, Zhou K, Shen B, Liang H, Jiang X. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci. 2014;15:10567-10577.
26. Ayaz L, Cayan F, Balci S, Gorur A, Akbayir S, Yildirim YH, Dogruer UN, Tamer L. Circulating microRNA expression profiles in ovarian cancer. J Obstet Gynaecol. 2014; 34:620-624.
27. Tumilson CA, Lea, RW, Alder, JE, Shaw, L. Circulating MicroRNA Biomarkers for Glioma and Predicting Response to Therapy. Mol Neurobiol. 2014;50:545-558.
28. Sui W, Liu, F, Chen, J, Ou, M, Dai, Y. Evaluating a particular circulating microRNA species from an SLE patient using stem-loop qRT-PCR. Methods Mol Biol. 2014;1134:201-209.
29. Pillai MM, Gillen, AE, Yamamoto, TM et al. HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer. Breast Cancer Res Treat 2014;146:85-97.
30. Poos K, Smida, J, Nathrath, M, Maugg, D, Baumhoer, D, Korsching, E. How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation. PLoS Comput Biol. 2013;9:e1003210.
31. Mitra R, Edmonds MD, Sun J, Zhao M, Yu H, Eischen CM, Zhao Z. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer. RNA. 2014; 20: 1356-1368.
32. Koens L, Qin Y, Leung WY, Corver WE, Jansen PM, Willemze R, Vermeer MH, Tensen CP. MicroRNA profiling of primary cutaneous large B-cell lymphomas. PLoS One. 2013; 8: e82471.
33. Fredman G, Li, Y, Dalli, J, Chiang, N, Serhan, CN. Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA. Sci Rep. 2012; 2: 639.
34. Lei H, Zou D, Li Z, Luo M, Dong L, Wang B, Yin H, Ma Y, Liu C, Wang F, Zhang J, Yu J, Li Y. MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation. PLoS One. 2013; 8: e60369.
35. de FO, Jr., Cui QL, Bin JM, Bull SJ, Kennedy TE, Bar-Or A, Antel JP, Colman DR, Dhaunchak AS. Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes. Front Genet 2012;3:46.
36. Shi W, Du J, Qi Y, Liang G, Wang T, Li S, Xie S, Zeshan B, Xiao Z. Aberrant expression of serum miRNAs in schizophrenia. J Psychiatr Res. 2012;46:198-204.
37. Wu JH, Gao Y, Ren AJ, Zhao SH, Zhong M, Peng YJ, Shen W, Jing M, Liu L. Altered microRNA expression profiles in retinas with diabetic retinopathy. Ophthalmic Res. 2012;47:195-201.